| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 617175 | 66184 | GABAPENTINA KERN PHARMA 800 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | GABAPENTINA KERN PHARMA 800 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 500 comprimidos | 800 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66184/66184_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66184/66184_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2004-06-30 | 1 | 1 | 1 | 2004-06-30 | 2004-06-30 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 620617 | 64891 | GABAPENTINA KERN PHARMA 400 mg CAPSULAS DURAS EFG | GABAPENTINA KERN PHARMA 400 mg CAPSULAS DURAS EFG , 500 cápsulas | 400 mg | 5 | 500 | 43 | 500 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64891/64891_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64891/64891_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2002-07-08 | 1 | 1 | 1 | 2002-07-08 | 2002-07-08 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 617019 | 04279005 | LYRICA 25 MG CAPSULAS DURAS | LYRICA 25 MG CAPSULAS DURAS 100 cápsulas | 25 mg | 5 | 100 | 43 | 100 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04279005/04279005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04279005/04279005_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | VIATRIS PHARMACEUTICALS S.L. | 2004-07-15 | 1 | 1 | 1 | 2004-07-15 | 2004-07-15 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 617142 | 04279019 | LYRICA 150 MG CAPSULAS DURAS | LYRICA 150 MG CAPSULAS DURAS, 100 cápsulas | 150 mg | 5 | 100 | 43 | 100 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04279019/04279019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04279019/04279019_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | VIATRIS PHARMACEUTICALS S.L. | 2004-07-15 | 1 | 1 | 1 | 2004-07-15 | 2004-07-15 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 607110 | 62825 | ADIRO 100 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ADIRO 100 MG COMPRIMIDOS GASTRORRESISTENTES EFG,100 comprimidos | 100 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62825/62825_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62825/62825_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 1999-12-10 | 1 | 1 | 1 | 2012-08-07 | 2018-11-29 | 1 | 2019-06-13 | View Edit Delete | ||||||||||||
| 607122 | 83756 | ERELAN 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ERELAN 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos | 400 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83756/83756_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83756/83756_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 28186 | MEDOCHEMIE IBERIA S.A. SUCURSAL EN ESPANA | 2019-01-11 | 1 | 1 | 1 | 2019-01-12 | 2019-01-11 | 0 | 2019-12-06 | View Edit Delete | ||||||||||||
| 608356 | 63046 | EMCONCOR COR 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | EMCONCOR COR 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 100 comprimidos | 2,5 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63046/63046_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63046/63046_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 88146 | MERCK S.L. | 2000-04-13 | 1 | 1 | 1 | 2000-04-13 | 2000-12-14 | 0 | 2018-11-21 | View Edit Delete | ||||||||||||
| 621326 | 63175 | PARAPRES PLUS 16 mg/12,5 mg COMPRIMIDOS | PARAPRES PLUS 16 mg/12,5 mg COMPRIMIDOS, 300 comprimidos | 16 mg/12,5 mg | 5 | 300 | 10 | 300 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63175/63175_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63175/63175_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | ALMIRALL S.A. | 2000-06-13 | 1 | 1 | 1 | 2000-06-13 | 2000-06-13 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 612283 | 61717 | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 500 comprimidos | 20 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61717/61717_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61717/61717_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 2000-11-14 | 1 | 1 | 1 | 2000-11-14 | 2001-01-09 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 615435 | 61718 | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 500 comprimidos | 40 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61718/61718_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61718/61718_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 2000-11-14 | 1 | 1 | 1 | 2000-11-14 | 2001-03-28 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 621904 | 62655 | CARDURAN NEO 4 mg COMPRIMIDOS DE LIBERACION MODIFICADA | CARDURAN NEO 4 mg COMPRIMIDOS DE LIBERACION MODIFICADA, 500 comprimidos | 4 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62655/62655_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62655/62655_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 2000-03-22 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 608000 | 55285 | MASDIL 60mg COMPRIMIDOS | MASDIL 60mg COMPRIMIDOS , 500 comprimidos | 60 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/55285/55285_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/55285/55285_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 1980-06-01 | 1 | 1 | 1 | 1980-06-01 | 1982-03-01 | 1 | 2011-06-07 | View Edit Delete | ||||||||||||
| 618173 | 63269 | ENALAPRIL BELMAC 20 mg COMPRIMIDOS EFG | ENALAPRIL BELMAC 20 mg COMPRIMIDOS EFG, 500 comprimidos | 20 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63269/63269_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63269/63269_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2000-07-21 | 1 | 1 | 1 | 2000-07-21 | 2000-07-21 | 1 | 2017-03-06 | View Edit Delete | ||||||||||||
| 619338 | 63568 | ENALAPRIL BELMAC 2,5 mg COMPRIMIDOS | ENALAPRIL BELMAC 2,5 mg COMPRIMIDOS, 500 comprimidos | 2,5 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63568/63568_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63568/63568_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2001-01-10 | 1 | 1 | 1 | 2001-01-10 | 2001-01-10 | 1 | 2013-02-11 | View Edit Delete | ||||||||||||
| 619346 | 63567 | ENALAPRIL BELMAC 10 mg COMPRIMIDOS | ENALAPRIL BELMAC 10 mg COMPRIMIDOS, 500 comprimidos | 10 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63567/63567_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63567/63567_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2001-01-10 | 1 | 1 | 1 | 2001-01-10 | 2001-01-10 | 1 | 2013-02-11 | View Edit Delete | ||||||||||||
| 607767 | 54626 | AMITRON 500 MG CÁPSULAS DURAS | AMITRON 500 MG CÁPSULAS DURAS, 100 cápsulas | 500 mg | 5 | 100 | 43 | 100 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/54626/54626_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/54626/54626_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1626 | LAPHYSAN S.A.U. | 1980-05-01 | 1 | 1 | 1 | 2013-10-28 | 2024-03-07 | 0 | 2025-11-10 | View Edit Delete | ||||||||||||
| 607611 | 88467 | QUIROCROM 20 MG/ML + 0,70 ML/ML SOLUCION CUTANEA | QUIROCROM 20 MG/ML + 0,70 ML/ML SOLUCION CUTANEA, 15 frascos | 20 mg/ml + 0,70 mg/ml | 6 | 3750 | 26 | 15 frascos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88467/88467_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88467/88467_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 2022-12-28 | 1 | 1 | 1 | 2022-12-29 | 2022-12-28 | 1 | 2023-01-31 | View Edit Delete | ||||||||||||
| 607612 | 88469 | CRISTALMINA PLUS 20 MG/ML + 0,70 ML/ML SOLUCIÓN PARA PULVERIZACIÓN CUTÁNEA | CRISTALMINA PLUS 20 MG/ML + 0,70 ML/ML SOLUCIÓN PARA PULVERIZACIÓN CUTÁNEA, 30 frascos de 125 ml | 20 mg/ml + 0,7 mg/ml | 6 | 3750 | 26 | 30 frascos de 125 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88469/88469_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88469/88469_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 2022-12-30 | 1 | 1 | 1 | 2022-12-31 | 2022-12-30 | 0 | 2023-01-31 | View Edit Delete | ||||||||||||
| 618967 | 63007 | NORMOFUNDINA CON POTASIO SOLUCIÓN PARA PERFUSIÓN | NORMOFUNDINA CON POTASIO SOLUCIÓN PARA PERFUSIÓN , 10 frascos de 500 ml | N/A (más de 4 PA) | 6 | 10 | 48 | 10 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63007/63007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63007/63007_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 2000-04-17 | 1 | 1 | 1 | 2000-04-17 | 2000-04-17 | 0 | 2011-06-20 | View Edit Delete | ||||||||||||
| 618975 | 63007 | NORMOFUNDINA CON POTASIO SOLUCIÓN PARA PERFUSIÓN | NORMOFUNDINA CON POTASIO SOLUCIÓN PARA PERFUSIÓN , 10 frascos de 1.000 ml | N/A (más de 4 PA) | 6 | 10 | 48 | 10 frascos de 1.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63007/63007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63007/63007_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 2000-04-17 | 1 | 1 | 1 | 2000-04-17 | 2000-04-17 | 0 | 2011-06-20 | View Edit Delete |
Page 31 of 1035, showing 20 records out of 20697 total, starting on record 601, ending on 620